Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Biull Eksp Biol Med ; 114(11): 500-2, 1992 Nov.
Artigo em Russo | MEDLINE | ID: mdl-1337842

RESUMO

New enkephalins analogues have been synthesized. They are characterized by linear, cyclic and branched peptide chain. A relationship has been established between antihypoxic activity of opioid peptides an their interaction with opiate receptors. Compounds efficiently interacting with mu-receptors irrespective of delta-receptors affinity, promote longer survival of mice in hypoxia. The antihypoxic effect of opioids is proportional to their specificity to mu-receptors.


Assuntos
Encefalinas/farmacologia , Hipóxia/tratamento farmacológico , Receptores Opioides/efeitos dos fármacos , Animais , Avaliação Pré-Clínica de Medicamentos , Encefalinas/síntese química , Encefalinas/uso terapêutico , Cobaias , Hipóxia/mortalidade , Técnicas In Vitro , Masculino , Camundongos , Camundongos Endogâmicos , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Relação Estrutura-Atividade
3.
Patol Fiziol Eksp Ter ; (5-6): 34-6, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1302825

RESUMO

The authors examined 56 patients with obliterating diseases (OD) of arteries of the lower extremities and conducted experiments on 97 male albino rats. In patients with OD the lactate content in the regional venous blood of the involved extremity increases proportionally to the severity of ischemia. No essential changes occur in the concentration of ATP and glucose. In rats with transitory ischemia of the extremities the lactate level in venous blood increases in the absence of changes of the ATP and glucose content; reduced concentration of ATP and glycogen was encountered in the ischemic muscles of the extremities. The mechanisms and significance of the disorders of metabolic parameters in ischemia are discussed.


Assuntos
Extremidades/irrigação sanguínea , Isquemia/metabolismo , Adulto , Animais , Artérias , Humanos , Isquemia/sangue , Masculino , Pessoa de Meia-Idade , Ratos , Ratos Wistar , Fluxo Sanguíneo Regional
4.
Khirurgiia (Mosk) ; (11): 33-6, 1990 Nov.
Artigo em Russo | MEDLINE | ID: mdl-2292851

RESUMO

Fifty-seven patients with obliterating diseases of the lower limb arteries were examined. The concentration of lactate in the venous blood and the venous-arterial difference in the blood lactate level in the affected limb were found to be increased. A relationship between the marked character of these shifts and the severity of the ischemic syndrome was noted. The authors discuss the possibility of using the values of the lactate content in the regional blood as criteria for evaluating the efficacy of treatment and the prognosis of obliterating diseases of the lower limb arteries.


Assuntos
Arteriosclerose Obliterante/sangue , Angiopatias Diabéticas/sangue , Endarterite/sangue , Lactatos/sangue , Perna (Membro)/irrigação sanguínea , Adulto , Artéria Femoral , Veia Femoral , Humanos , Masculino
5.
Kardiologiia ; 30(7): 77-9, 1990 Jul.
Artigo em Russo | MEDLINE | ID: mdl-2232471

RESUMO

Eighty seven patients with Stages II-III vascular occlusions in the lower extremities were examined. The clinical and biochemical parameters of the course of the disease were found to improve in the patients who received in earlier periods dalargin supplemented to the combined therapy than in those from a matched group. There was a decrease in femoral venous blood lactate concentrations in the diseased extremity, blood cholesterol and parathyroid hormone levels. The mechanisms responsible for effects of dalargin on metabolic parameters and clinical indices of the patients' condition were also discussed. Whether it is possible to use dalargin in the combined therapy for extremity vascular occlusive diseases is considered.


Assuntos
Arteriosclerose Obliterante/tratamento farmacológico , Colesterol/sangue , Leucina Encefalina-2-Alanina/análogos & derivados , Lactatos/sangue , Perna (Membro)/irrigação sanguínea , Hormônio Paratireóideo/sangue , Adulto , Anticolesterolemiantes , Arteriosclerose Obliterante/sangue , Leucina Encefalina-2-Alanina/uso terapêutico , Humanos , Lactatos/antagonistas & inibidores , Masculino , Pessoa de Meia-Idade , Hormônio Paratireóideo/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA